Biological influence of Hakai in cancer: A 10-year review

Cancer and Metastasis Reviews

Volumn 31, Issue 1-2, 2012, Pages 375-386

  Aparicio, Luis A ^a   Valladares, Manuel ^a   Blanco, Moisés ^a   Alonso, Guillermo ^a   Figueroa, Angélica ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

E cadherin; E3 ubiquitin ligase; Epithelial mesenchymal transition; Hakai

Indexed keywords

BETA CATENIN; CATENIN; CBL PROTEIN; CORTACTIN; CYCLIN D1; DESMOCOLLIN; DESMOGLEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR RECEPTOR; FRIZZLED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; P CADHERIN; PAXILLIN; PROTEIN HAKAI; PROTEIN KINASE P60; PROTEIN P120; PROTEIN TYROSINE KINASE; RAB PROTEIN; RAB7 PROTEIN; RAF PROTEIN; RECEPTOR FOR ACTIVATED C KINASE 1; ROUNDABOUT RECEPTOR; SCATTER FACTOR RECEPTOR; SLIT2 PROTEIN; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN;

ACTIN FILAMENT; AMINO ACID SEQUENCE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; COLON ADENOCARCINOMA; CRYSTAL STRUCTURE; DESMOSOME; DOWN REGULATION; DROSOPHILA; ENDOCYTOSIS; EPITHELIAL MESENCHYMAL TRANSITION; FLAVIVIRUS INFECTION; HUMAN; IMMUNE DEFICIENCY; IN VIVO STUDY; INTERNALIZATION; INTRACELLULAR SIGNALING; LISTERIOSIS; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROLINE RICH PROTEIN DOMAIN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RING FINGER MOTIF; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TUMOR GROWTH; UBIQUITINATION; UPREGULATION; VIRUS ENTRY; WEST NILE FLAVIVIRUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CADHERINS; CELL ADHESION; HUMANS; INTERCELLULAR JUNCTIONS; MOLECULAR TARGETED THERAPY; NEOPLASMS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84862308542     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9348-x     Document Type: Review

References (103)

1. Thiery, J. P., & Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nature Reviews Molecular Cell Biology, 7(2), 131-142. (Pubitemid 43278296)
2. Hanahan, D., &Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57-70. (Pubitemid 30046295)
3. Birchmeier, W., & Behrens, J. (1994). Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochimica et Biophysica Acta, 1198(1), 11-26. (Pubitemid 24159061)
4. Christofori, G., & Semb, H. (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends in Biochemical Sciences, 24(2), 73-6. (Pubitemid 29346577)
5. Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature, 392(6672), 190-193. (Pubitemid 28162793)
6. Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & van Roy, F. (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66 (1), 107-119. (Pubitemid 121001351)
7. Berx, G., & Van Roy, F. (2009). Involvement of members of the cadherin superfamily in cancer (pp. 1-27). Cold Spring Harbor: Cold Spring Harb Perspect Biol.
8. van Roy, F., & Berx, G. (2008). The cell-cell adhesion molecule E-cadherin. Cellular and Molecular Life Sciences, 65(23), 3756-3788.
9. Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H., Behrens, J., et al. (2002). Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nature Cell Biology, 4(3), 222-231. (Pubitemid 34218196)
10. Farquhar, M. G., & Palade, G. E. (1963). Junctional complexes in various epithelia. The Journal of Cell Biology, 17, 375-412.
11. D'Souza-Schorey, C. (2005). Disassembling adherens junctions: Breaking up is hard to do. Trends in Cell Biology, 15(1), 19-26.
12. Yoshida, C., & Takeichi, M. (1982). Teratocarcinoma cell adhesion: Identification of a cell-surface protein involved in calciumdependent cell aggregation. Cell, 28(2), 217-224. (Pubitemid 12132752)
13. Yoshida-Noro, C., Suzuki, N., & Takeichi, M. (1984). Molecular nature of the calcium-dependent cell-cell adhesion system in mouse teratocarcinoma and embryonic cells studied with a monoclonal antibody. Developmental Biology, 101(1), 19-27.
14. Peyriéras, N., Hyafil, F., Louvard, D., Ploegh, H. L., & Jacob, F. (1983). Uvomorulin: A nonintegral membrane protein of early mouse embryo. Proceedings of the National Academy of Sciences of the United States of America, 80(20), 6274-6277. (Pubitemid 14228368)
15. Gallin, W. J., Edelman, G. M., & Cunningham, B. A. (1983). Characterization of L-CAM, a major cell adhesion molecule from embryonic liver cells. Proceedings of the National Academy of Sciences of the United States of America, 80(4), 1038-1042. (Pubitemid 13118081)
16. Volk, T., & Geiger, B. (1984). A 135-kd membrane protein of intercellular adherens junctions. EMBO Journal, 3(10), 2249-2260.
17. Angst, B. D., Marcozzi, C., & Magee, A. I. (2001). The cadherin superfamily. Journal of Cell Science, 114(Pt 4), 625-626. (Pubitemid 32237134)
18. Nakanishi, H., & Takai, Y. (2004). Roles of nectins in cell adhesion, migration and polarization. Biological Chemistry, 385 (10), 885-892. (Pubitemid 39481135)
19. Takeichi, M. (1988). The cadherins: Cell-cell adhesion molecules controlling animal morphogenesis. Development, 102(4), 639-655.
20. Overduin, M., Harvey, T. S., Bagby, S., Tong, K. I., Yau, P., Takeichi, M., et al. (1995). Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science, 267(5196), 386-389.
21. Nishimura, T., & Takeichi, M. (2009). Remodeling of the adherens junctions during morphogenesis. Current Topics in Developmental Biology, 89, 33-54.
22. Pokutta, S., & Weis, W. I. (2007). Structure and mechanism of cadherins and catenins in cell-cell contacts. Annual Review of Cell and Developmental Biology, 23, 237-261.
23. Perez-Moreno, M., & Fuchs, E. (2006). Catenins: Keeping cells from getting their signals crossed. Developmental Cell, 11(5), 601-612. (Pubitemid 44644972)
24. Drees, F., Pokutta, S., Yamada, S., Nelson, W. J., & Weis, W. I. (2005). Alpha-catenin is a molecular switch that binds Ecadherin-beta-catenin and regulates actin-filament assembly. Cell, 123(5), 903-915. (Pubitemid 41721035)
25. Yamada, S., Pokutta, S., Drees, F., Weis, W. I., & Nelson, W. J. (2005). Deconstructing the cadherin-catenin-actin complex. Cell, 123(5), 889-901. (Pubitemid 41721034)
26. Behrens, J., Vakaet, L., Friis, R., Winterhager, E., Van Roy, F., Mareel, M. M., et al. (1993). Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature- sensitive v-SRC gene. The Journal of Cell Biology, 120(3), 757-766. (Pubitemid 23035144)
27. Stoker, M., & Gherardi, E. (1991). Regulation of cell movement: The motogenic cytokines. Biochimica et Biophysica Acta, 1072 (1), 81-102. (Pubitemid 121007531)
28. Lipkowitz, S., & Weissman, A. M. (2011). RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nature Reviews. Cancer, 11(9), 629-643.
29. Frame, M. C., Fincham, V. J., Carragher, N. O., & Wyke, J. A. (2002). v-Src's hold over actin and cell adhesions. Nature Reviews Molecular Cell Biology, 3(4), 233-245. (Pubitemid 34619259)
30. Hicke, L., & Riezman, H. (1996). Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Cell, 84(2), 277-287.
31. Le, T. L., Yap, A. S., & Stow, J. L. (1999). Recycling of Ecadherin: A potential mechanism for regulating cadherin dynamics. The Journal of Cell Biology, 146(1), 219-232. (Pubitemid 29349976)
32. Palacios, F., Price, L., Schweitzer, J., Collard, J. G., & D'Souza-Schorey, C. (2001). An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO Journal, 20(17), 4973-4986. (Pubitemid 32848649)
33. Palacios, F., Tushir, J., Fujita, Y., & D'Souza-Schorey, C. (2005). Lysosomal targeting of E-cadherin: A unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Molecular and Cellular Biology, 25(1), 389-402. (Pubitemid 40039828)
34. Weidner, K. M., Behrens, J., Vandekerckhove, J., & Birchmeier, W. (1990). Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol, 5, 2097-2108.
35. Takeichi, M. (1995). Morphogenetic roles of classic cadherins. Current Opinion in Cell Biology, 7(5), 619-627.
36. Gumbiner, B. M. (2000). Regulation of cadherin adhesive activity. The Journal of Cell Biology, 148(3), 399-404.
37. Ishiyama, N., Lee, S., Liu, S., Li, G., Smith, M., Reichardt, L., et al. (2010). Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion. Cell, 141(1), 117-128.
38. Reynolds, A. B. (2010). Exposing p120 catenin's most intimate affair. Cell, 141(1), 20-22.
39. Potter, M. D., Barbero, S., & Cheresh, D. A. (2005). Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. The Journal of Biological Chemistry, 280(36), 31906-31912. (Pubitemid 41291941)
40. Reynolds, A. B., & Roczniak-Ferguson, A. (2004). Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene, 23(48), 7947-7956. (Pubitemid 39468853)
41. Chen, K. H., Tung, P. Y., Wu, J. C., Chen, Y., Chen, P. C., Huang, S. H., et al. (2008). An acidic extracellular pH induces Src kinase-dependent loss of beta-catenin from the adherens junction. Cancer Letters, 267(1), 37-48.
42. Parks, S. K., Chiche, J., & Pouyssegur, J. (2011). pH control mechanisms of tumor survival and growth. Journal of Cellular Physiology, 226(2), 299-308.
43. Neri, D., & Supuran, C. T. (2011). Interfering with pH regulation in tumours as a therapeutic strategy. Nature Reviews Drug Discovery, 10(10), 767-77.
44. Chen, Y., Chen, C., Tung, P., Huang, S., & Wang, S. (2009). An acidic extracellular pH disrupts adherens junctions in HepG2 cells by Src kinases-dependent modification of E-cadherin. Journal of Cellular Biochemistry, 108(4), 851-859.
45. Kaido, M., Wada, H., Shindo, M., & Hayashi, S. (2009). Essential requirement for RING finger E3 ubiquitin ligase Hakai in early embryonic development of Drosophila. Genes to Cells, 14(9), 1067-1077.
46. Ardley, H. C., & Robinson, P. A. (2005). E3 ubiquitin ligases. Essays in Biochemistry, 41, 15-30. (Pubitemid 41500968)
47. Jackson, P. K., Eldridge, A. G., Freed, E., Furstenthal, L., Hsu, J. Y., Kaiser, B. K., et al. (2000). The lore of the RINGs: Substraterecognition and catalysis by ubiquitin ligases. Trends in Cell Biology, 10(10), 429-439.
48. Joazeiro, C. A., Wing, S. S., Huang, H., Leverson, J. D., Hunter, T., & Liu, Y. C. (1999). The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science, 286(5438), 309-312. (Pubitemid 29484697)
49. Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., et al. (1999). Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Molecular Cell, 4(6), 1029-1040. (Pubitemid 30054908)
50. Mukherjee, M., Chow, S. Y., Yusoff, P., Seetharaman, J., Ng, C., Sinniah, S., et al. (2012). Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin. EMBO Journal. doi:emboj2011496.
51. Liu, Y., Bai, G., Zhang, H., Su, D., Tao, D., Yang, Y., et al. (2010). Human RING finger protein ZNF645 is a novel testis-specific E3 ubiquitin ligase. Asian Journal of Andrology, 12(5), 658-66.
52. Shen, Y., Hirsch, D. S., Sasiela, C. A., &Wu,W. J. (2008). Cdc42 regulates E-cadherin ubiquitination and degradation through an epidermal growth factor receptor to Src-mediated pathway. Journal of Biological Chemistry, 283(8), 5127-5137.
53. Ishizawar, R., & Parsons, S. J. (2004). c-Src and cooperating partners in human cancer. Cancer Cell, 6(3), 209-214. (Pubitemid 39222033)
54. Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nature Reviews Cancer, 2(6), 442-454.
55. Braga, V. (2000). Epithelial cell shape: Cadherins and small GTPases. Experimental Cell Research, 261(1), 83-90.
56. Sahai, E., & Marshall, C. J. (2002). RHO-GTPases and cancer. Nature Reviews Cancer, 2(2), 133-142.
57. Bryant, D. M., & Stow, J. L. (2004). The ins and outs of Ecadherin trafficking. Trends in Cell Biology, 14(8), 427-434.
58. Chang, B. Y., Conroy, K. B., Machleder, E. M., & Cartwright, C. A. (1998). RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells. Molecular and Cellular Biology, 18(6), 3245-3256. (Pubitemid 28240497)
59. Chang, B. Y., Chiang, M., & Cartwright, C. A. (2001). The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1. Journal of Biological Chemistry, 276(23), 20346-20356.
60. Chang, B. Y., Harte, R. A., & Cartwright, C. A. (2002). RACK1: A novel substrate for the Src protein-tyrosine kinase. Oncogene, 21(50), 7619-7629. (Pubitemid 35398809)
61. Mamidipudi, V., Zhang, J., Lee, K. C., & Cartwright, C. A. (2004). RACK1 regulates G1/S progression by suppressing Src kinase activity. Molecular and Cellular Biology, 24(15), 6788-6798. (Pubitemid 38944357)
62. Mamidipudi, V., & Cartwright, C. A. (2009). A novel proapoptotic function of RACK1: Suppression of Src activity in the intrinsic and Akt pathways. Oncogene, 28(50), 4421-4433.
63. Mamidipudi, V., Dhillon, N. K., Parman, T., Miller, L. D., Lee, K. C., & Cartwright, C. A. (2007). RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints. Oncogene, 26(20), 2914-2924. (Pubitemid 46701439)
64. Swaminathan, G., & Cartwright, C. A. (2011). Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis. Oncogene, 31(3), 376-89.
65. Xu, J., Lamouille, S., & Derynck, R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Research, 19(2), 156-172.
66. Lehmann, K., Janda, E., Pierreux, C. E., Rytömaa, M., Schulze, A., McMahon, M., et al. (2000). Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: A mechanism leading to increased malignancy in epithelial cells. Genes & Development, 14(20), 2610-2622.
67. Janda, E., Lehmann, K., Killisch, I., Jechlinger, M., Herzig, M., Downward, J., et al. (2002). Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: Dissection of Ras signaling pathways. The Journal of Cell Biology, 156(2), 299-313. (Pubitemid 34839911)
68. Janda, E., Nevolo, M., Lehmann, K., Downward, J., Beug, H., & Grieco, M. (2006). Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin. Oncogene, 54, 7117-7130. (Pubitemid 44764181)
69. Dickson, B. J., & Gilestro, G. F. (2006). Regulation of commissural axon pathfinding by slit and its Robo receptors. Annual Review of Cell and Developmental Biology, 22, 651-675.
70. Wu, J. Y., Feng, L., Park, H. T., Havlioglu, N.,Wen, L., Tang, H., et al. (2001). The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature, 410(6831), 948-952. (Pubitemid 32335842)
71. Wang, B., Xiao, Y., Ding, B. B., Zhang, N., Yuan, X., Gui, L., et al. (2003). Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell, 4(1), 19-29. (Pubitemid 36904158)
72. Wang, L. J., Zhao, Y., Han, B., Ma, Y. G., Zhang, J., Yang, D. M., et al. (2008). Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. Cancer Science, 99(3), 510-517. (Pubitemid 351228567)
73. Mertsch, S., Schmitz, N., Jeibmann, A., Geng, J. G., Paulus, W., & Senner, V. (2008). Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. Journal of Neuro-Oncology, 87(1), 1-7. (Pubitemid 351167863)
74. Zhou, W. J., Geng, Z. H., Chi, S., Zhang, W., Niu, X. F., Lan, S. J., et al. (2011). Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Research, 21(4), 609-626.
75. Shav-Tal, Y., & Zipori, D. (2002). PSF and p54(nrb)/NonO-multi- functional nuclear proteins. FEBS Letters, 531(2), 109-114.
76. Cobbold, L. C., Spriggs, K. A., Haines, S. J., Dobbyn, H. C., Hayes, C., de Moor, C. H., et al. (2008). Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs. Molecular and Cellular Biology, 28(1), 40-49.
77. Kaneko, S., Rozenblatt-Rosen, O., Meyerson, M., & Manley, J. L. (2007). The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3' processing and transcription termination. Genes & Development, 21(14), 1779-1789. (Pubitemid 47076477)
78. Figueroa, A., Kotani, H., Toda, Y., Mazan-Mamczarz, K., Mueller, E., Otto, A., et al. (2009). Novel roles of hakai in cell proliferation and oncogenesis. Molecular Biology of the Cell, 20(15), 3533-3542.
79. Figueroa, A., Fujita, Y., & Gorospe, M. (2009). Hacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSF. Cell Cycle, 8(22), 3648-3651.
80. Gong, E., Park, E., & Lee, K. (2010). Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells. Cancer Science, 101(9), 2019-2025.
81. Fan, S., Ma, Y. X.,Wang, C., Yuan, R. Q., Meng, Q.,Wang, J. A., et al. (2001). Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene, 20(1), 77-87. (Pubitemid 32142340)
82. Johnsen, S. A., Güngör, C., Prenzel, T., Riethdorf, S., Riethdorf, L., Taniguchi-Ishigaki, N., et al. (2009). Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer. Cancer Research, 69(1), 128-136.
83. Zilfou, J. T., Hoffman, W. H., Sank, M., George, D. L., & Murphy, M. (2001). The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation. Molecular and Cellular Biology, 21(12), 3974-3985. (Pubitemid 32476459)
84. Chen, G., & Courey, A. J. (2000). Groucho/TLE family proteins and transcriptional repression. Gene, 249(1-2), 1-16.
85. Iyemere, V. P., Davies, N. H., & Brownlee, G. G. (1998). The activation function 2 domain of hepatic nuclear factor 4 is regulated by a short C-terminal proline-rich repressor domain. Nucleic Acids Research, 26(9), 2098-2104.
86. Deshaies, R. J., & Joazeiro, C. A. (2009). RING domain E3 ubiquitin ligases. Annual Review of Biochemistry, 78, 399-434.
87. Rodríguez-Rigueiro, T., Valladares-Ayerbes, M., Haz-Conde, M., Blanco, M., Aparicio, G., Fernández-Puente, P., et al. (2011). A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues. Proteomics, 11(12), 2555-2559.
88. Hogan, C., Dupré-Crochet, S., Norman, M., Kajita, M., Zimmermann, C., Pelling, A. E., et al. (2009). Characterization of the interface between normal and transformed epithelial cells. Nature Cell Biology, 11(4), 460-467.
89. Rodríguez-Rigueiro, T., Valladares-Ayerbes, M., Haz-Conde, M., Aparicio, L. A., & Figueroa, A. (2011). Hakai reduces cell-substratum adhesion and increases epithelial cell invasion. BMC Cancer, 11, 474. doi:1471-2407-11-474.
90. Singh, R. P., Raina, K., Deep, G., Chan, D., & Agarwal, R. (2009). Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling. Clinical Cancer Research, 15(2), 613-621.
91. Raina, K., Rajamanickam, S., Singh, R. P., Deep, G., Chittezhath, M., & Agarwal, R. (2008). Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model. Cancer Research, 68(16), 6822-6830.
92. Singh, R. P., Raina, K., Sharma, G., & Agarwal, R. (2008). Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelialmesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice. Clinical Cancer Research, 14(23), 7773-7780.
93. Deep, G., Gangar, S., Agarwal, C., & Agarwal, R. (2011). Role of E-cadherin in anti-migratory and anti-invasive efficacy of silibinin in prostate cancer cells. Cancer Prevention Research (Philadelphia, Pa.), 4(8), 1222-1232.
94. Flaig, T. W., Gustafson, D. L., Su, L. J., Zirrolli, J. A., Crighton, F., Harrison, G. S., et al. (2007). A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Investigational New Drugs, 25(2), 139-146. (Pubitemid 46020872)
95. Heo, H. S., Kim, J. H., Lee, Y. J., Kim, S. H., Cho, Y. S., & Kim, C. G. (2005). Microarray profiling of genes differentially expressed during erythroid differentiation of murine erythroleukemia cells. Molecules and Cells, 20(1), 57-68.
96. Oshida, K., Maeda, A., Kitsukawa, M., Suga, S., Iwano, S., Miyoshi, T., et al. (2011). Novel gene markers of immunosuppressive chemicals in mouse lymph node assay. Toxicology Letters, 205(1), 79-85.
97. Krishnan, M., Ng, A., Sukumaran, B., Gilfoy, F., Uchil, P., Sultana, H., et al. (2008). RNA interference screen for human genes associated with West Nile virus infection. Nature, 455 (7210), 242-245.
98. Brinton, M. A. (2002). The molecular biology of West Nile Virus: A new invader of the western hemisphere. Annual Review of Microbiology, 56, 371-402.
99. Fernandez-Garcia, M. D., Meertens, L., Bonazzi, M., Cossart, P., Arenzana-Seisdedos, F., & Amara, A. (2011). Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication. Journal of Virology, 85(6), 2980-2989.
100. Lecuit, M. (2005). Understanding how Listeria monocytogenes targets and crosses host barriers. Clinical Microbiology and Infection, 11(6), 430-436.
101. Mengaud, J., Ohayon, H., Gounon, P., Mege, R. M., & Cossart, P. (1996). E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell, 84(6), 923-932. (Pubitemid 26106861)
102. Shen, Y., Naujokas, M., Park, M., & Ireton, K. (2000). InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase. Cell, 103(3), 501-510.
103. Bonazzi, M., Veiga, E., Pizarro-Cerdá, J., & Cossart, P. (2008). Successive post-translational modifications of E-cadherin are required for InlA-mediated internalization of Listeria monocytogenes. Cellular Microbiology, 10(11), 2208-2222.